Strategic acquisitions Lockwood is actively expanding through multiple acquisitions (Total Health Oncology, Research To Practice, IDEO Hematology) to broaden capabilities in medical education and oncology-focused expertise, signaling opportunities to cross-sell enhanced education, multichannel engagement, and regulatory/clinical consulting services.

Full-service platform As a global health care services platform offering medical communications, education, animation, regulatory and clinical consulting, and market access, there are cross-sell opportunities across the entire pharmaceutical lifecycle from early pipeline strategy to late-stage commercialization.

Therapeutic emphasis Strong oncology focus from recent acquisitions suggests growth opportunities with cancer care providers, patient education programs, and pharma sponsors seeking oncology-focused medical education, publications, and stakeholder engagement solutions.

Quality and credibility Emphasis on scientific rigor, quality, integrity, and collaboration positions Lockwood as a trusted partner for high-stakes communications, creating upsell potential for compliance-led content, publication planning, and independent medical education initiatives.

Growth through scale Significant revenue footprint and employee base coupled with ongoing integrations indicate capacity to take on larger, multi-region engagements, offering enterprise-scale programs, global medical affairs support, and coordinated multichannel campaigns for sponsors.